Study: Hispanic Adults, Women, and Older E-cigarette Users Face Higher Odds of Asthma and COPD
October 20, 2021

CHEST 2021: Study shows vaping raises the odds of developing asthma and COPD, especially in older adults, women, and Hispanic persons.

Dupilumab Associated with Reduced Oral Corticosteroids in Severe Asthma, Regardless of Baseline OCS Dose
October 18, 2021

In patients with severe asthma dependent on OCS, dupilumab reduced OCS dose and improved the odds of no longer requiring OCS, suggests research presented at CHEST 2021.

Tezepelumab May Improve Peak Expiratory Flow in Patients with Severe Asthma, Suggests Analysis of NAVIGATOR Trial
October 14, 2021

CHEST 2021: Patients with severe asthma who received tezepelumab compared with placebo demonstrated rapid improvement in morning and evening peak expiratory flow.

Multidisciplinary Asthma Care: It Takes a Village
October 29, 2015

Effective asthma care requires attention to comorbidities, complications, and human characteristics of each patient. Speakers at CHEST 2015 described "the village."

Clinical Evolution in Asthma and COPD
October 29, 2015

New approaches discussed at CHEST 2015 ranged from the impact of bariatric surgery on asthma control to endobronchial valve placement in COPD.

Emerging Pharmacotherapy in COPD: Update from CHEST 2015
October 29, 2015

In a well-attended session at CHEST 2015 a number of promising new therapies for treating COPD were reviewed by study authors.

Safety of COPD Medications: Current Evidence
October 28, 2015

COPD is one of the primary lung diseases seen in primary care. A CHEST 2015 panel session reinforced that treatment is often a risk/benefit balance.

Consistent Asthma Control: One Patient at a Time
October 28, 2015

The best asthma care is not good enough if the patient is nonadherent. Applied "humanomics" as an approach to chronic care was discussed this week at CHEST 2015.

Primary Care Management of Multimorbidity: COPD, for Example
October 28, 2015

Exacerbations of COPD often complicate CV outcomes. Two studies presented at CHEST 2015 looked at ways to refine risk factors for CV decline.

Steroid-sparing Rx for Severe Asthma: What is In the Pipeline?
October 27, 2015

Severe refractory asthma resists conventional therapies, but a roster of new biologics, discussed at CHEST 2015 in Montreal, may soon offer relief.